DJIA 16,654.77 369.26 2.27%
NASDAQ 4,812.71 115.17 2.45%
S&P 500 1,987.66 47.15 2.43%
market minute promo

28.55 0.30 (1.06%)

Quote as of


company name or ticker

Recent Quotes

XLRN $28.55 1.06%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.55
Previous Close $28.25
Daily Range $27.54 - $29.34
52-Week Range $20.00 - $48.50
Market Cap $943.8M
P/E Ratio -18.11
Dividend (Yield) $0.00 (0.0%)
Volume 197,690
Average Daily Volume 179,719
Current FY EPS -$1.11

Sector

Industry

CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description

CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/

News & Commentary Rss Feed

Stocks To Watch in Orphan Drugs

Acceleron Pharma, bluebird bio, and Sarepta Therapeutics are three rare disease specialists with upcoming catalysts that could propel their shares higher.

Avalanche Biotechnologies (AAVL) Q2 Loss Narrows Y/Y

Acceleron Pharma (XLRN) Moves 13.3% Higher in Session

Acceleron Pharma (XLRN) Highlighted As Weak On High Volume

Acceleron Pharma (XLRN) CEO John Knopf on Q2 2015 Results - Earnings Call Transcript

XLF, UBIO: Big ETF Inflows

Acceleron Pharma Has 2 Drug Candidates That Could Become Blockbusters

Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX

Celgene Rapid Growth Is Still Ahead For 2016 Through 2020

Multiple Observations On Celgene's Latest Licensing Deals, And Its Valuation

Acceleron Reports Publication in Cancer Research Dalantercept Prevents Metastases in Preclinical Stu

Acceleron Reports Publication in Cancer Research Dalantercept Prevents Metastases in Preclinical Studies of Breast Cancer

See More XLRN News...